Aumenta le possibilità di ricevere una risposta da questo datore di lavoro
Il tuo curriculum e una lettera di presentazione personalizzati, che corrispondono esattamente a ciò che sta cercando.
Recipharm is seeking an Senior Manager of Financial Planning & Analysis at the Watertown, MA facility to lead budgeting, forecasting, and management reporting. The role partners with executive leadership to drive financial performance and strategic initiatives, including S&OP support, pricing analysis, and investment reviews.
The ideal candidate has 5+ years of FP&A leadership experience in manufacturing or life sciences, strong analytical skills, and proficiency with D365 and Tagetik, plus
The Senior Manager, Financial Planning & Analysis (FP&A) at the Watertown, MA facility is responsible for leading the financial planning, budgeting, forecasting, management reporting, and business decision support functions for the organization. This role partners closely with executive leadership and site management teams to drive financial performance, improve forecasting accuracy, support strategic initiatives, and provide actionable financial insights.
Reporting to the Head of Finance, this position oversees FP&A activities across multiple sites and serves as a key business partner in evaluating profitability, cash flow, investment opportunities, and operational performance.
Annual Base Salary Range: $165,000 - $175,000
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) employing over 4,500 employees worldwide. Recipharm provides manufacturing services of pharmaceuticals in various dosage forms, including, sterile fill & finish, oral solid dosage and biologics; clinical trial material development and manufacturing services; and, pharmaceutical product development. Its biologics segment, ReciBioPharm, works with customers to develop and commercialise advanced therapy medicinal products (ATMPs): pre-clinical to clinical and commercial development and manufacture for new biological modalities, encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. It operates development and manufacturing facilities in France, Germany, India, Italy, Portugal, Spain, Sweden and the US and is headquartered in Stockholm, Sweden.
For more information on Recipharm and our services, please visit www.recipharm.com and www.recibiopharm.com